February 8, 2023 (South San Francisco, CA) — We are excited to announce that we have been selected to participate in Imagine H2O’s 2023 Accelerator Program.

February 1, 2023 (West Lafayette, IN & South San Francisco, CA) - Purdue Ag-Celerator fund invests $100,000 in OmniVis.

January 24, 2023 (South San Francisco, CA) — The article entitled, “Quantifying Brownian motion in the presence of simple shear flow with particle diffusometry” was published in the peer-reviewed journal, Experiments in Fluids.

January 29, 2023 (South San Francisco, CA) — OmniVis was on Inside Indiana Business (IIB) on WTTV - CBS4 in Indianapolis.

January 17 2023 (South San Francisco, CA) — OmniVis was highlighted by the Purdue Research Foundation for winning the Most Fundable Companies designation from Pepperdine’s Graziadio Business School.

January 2023 (South San Francisco, CA) — OmniVis was chosen as a top seed funded startup in the AgTech space in the USA by Just Funded.

This November (2022), we were featured in Entrepreneur Magazine for winning the Pepperdine Most Fundable Company award. We are honored to be amongst the many great entrepreneurs this year who are solving big problems.

OmniVis wins gold at the 2022 Most Fundable Company competition from Pepperdine’s Graziadio School of Management. 16 winners were chosen from 4000 applicants in this prestigious competition.

South San Francisco (September 2022) --- OmniVis has been awarded a Technology Enhancement for Commercial Partnerships (TECP) grant, a supplemental funding mechanism to OmniVis’ current National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II award.

OmniVis published with collaborators at Purdue University on the detection of the COVID-19 causing pathogen in saliva samples.

OmniVis Inc. will receive computing credits and customized expertise from Amazon’s cloud computing arm for a rapid, handheld pathogen detection device.

OmniVis is one of the fifty US entrepreneur recipients, representing all US regions across a variety of industries, to win the Alibaba Grants program for US$10,000.

OmniVis published with collaborators at Purdue University and IUSM on malaria detection in patient blood samples.

OmniVis published with collaborators at icddr,b and University of Notre Dame on their 2019 study on device usability.

OmniVis joins the Bay Area Global Health Alliance (BAGHI) in our commitment to equity and innovation in global health. OmniVis is excited to join an alliance with other organizations who are doing groundbreaking work in global health.

OmniVis was one of the winning teams for a $10,000 award to continue work on COVID-19. Thank you to Booz Allen Foundation for this generous award.

OmniVis has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant to conduct research and development (R&D) work on COVID-19 rapid detection technology. 

COVID-19 testing is still not accessible to every individual across the country therefore counties and states across the U.S. must take this into account when considering the effects of reopening businesses. This is where rapid diagnostics technology plays of utmost importance.

Read about how Microsoft is supporting social entrepreneurship startups such as OmniVis in expanding technology for to fuel social innovation at a large scale.

OmniVis’s rapid disease detection technology is funded by the National Science Foundation (NSF) to develop quick and widespread diagnostics for cholera using our platform. With this new funding, we are excited to join the fight against infectious disease from cholera to applications in COVID-19.